VSIR and congenital rubella syndrome: Although not formally demonstrated with JNJ-61610588, based on in vitro studies showing IgG1-dependent myeloid activation, it appears likely that the coating of myeloid cells in the blood with an IgG1 anti-VISTA mAb led to activation in circulation, resulting in cytokine release syndrome (CRS).